These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 29152058)

  • 1. Effective control of acute myeloid leukaemia and acute lymphoblastic leukaemia progression by telomerase specific adoptive T-cell therapy.
    Sandri S; De Sanctis F; Lamolinara A; Boschi F; Poffe O; Trovato R; Fiore A; Sartori S; Sbarbati A; Bondanza A; Cesaro S; Krampera M; Scupoli MT; Nishimura MI; Iezzi M; Sartoris S; Bronte V; Ugel S
    Oncotarget; 2017 Oct; 8(50):86987-87001. PubMed ID: 29152058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feasibility of Telomerase-Specific Adoptive T-cell Therapy for B-cell Chronic Lymphocytic Leukemia and Solid Malignancies.
    Sandri S; Bobisse S; Moxley K; Lamolinara A; De Sanctis F; Boschi F; Sbarbati A; Fracasso G; Ferrarini G; Hendriks RW; Cavallini C; Scupoli MT; Sartoris S; Iezzi M; Nishimura MI; Bronte V; Ugel S
    Cancer Res; 2016 May; 76(9):2540-51. PubMed ID: 27197263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD19-Chimeric Antigen Receptor T Cells for Treatment of Chronic Lymphocytic Leukaemia and Acute Lymphoblastic Leukaemia.
    Lorentzen CL; Straten PT
    Scand J Immunol; 2015 Oct; 82(4):307-19. PubMed ID: 26099639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukemic fusion genes MLL/AF4 and AML1/MTG8 support leukemic self-renewal by controlling expression of the telomerase subunit TERT.
    Gessner A; Thomas M; Castro PG; Büchler L; Scholz A; Brümmendorf TH; Soria NM; Vormoor J; Greil J; Heidenreich O
    Leukemia; 2010 Oct; 24(10):1751-9. PubMed ID: 20686504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chimeric antigen receptor engineering: a right step in the evolution of adoptive cellular immunotherapy.
    Figueroa JA; Reidy A; Mirandola L; Trotter K; Suvorava N; Figueroa A; Konala V; Aulakh A; Littlefield L; Grizzi F; Rahman RL; Jenkins MR; Musgrove B; Radhi S; D'Cunha N; D'Cunha LN; Hermonat PL; Cobos E; Chiriva-Internati M
    Int Rev Immunol; 2015 Mar; 34(2):154-87. PubMed ID: 25901860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting of acute myeloid leukaemia by cytokine-induced killer cells redirected with a novel CD123-specific chimeric antigen receptor.
    Tettamanti S; Marin V; Pizzitola I; Magnani CF; Giordano Attianese GM; Cribioli E; Maltese F; Galimberti S; Lopez AF; Biondi A; Bonnet D; Biagi E
    Br J Haematol; 2013 May; 161(3):389-401. PubMed ID: 23432359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival for haematological malignancies in Europe between 1997 and 2008 by region and age: results of EUROCARE-5, a population-based study.
    Sant M; Minicozzi P; Mounier M; Anderson LA; Brenner H; Holleczek B; Marcos-Gragera R; Maynadié M; Monnereau A; Osca-Gelis G; Visser O; De Angelis R;
    Lancet Oncol; 2014 Aug; 15(9):931-42. PubMed ID: 25030467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pathogenesis and development of targeted drugs in acute T lymphoblastic leukaemia.
    Chen Z; Xin Q; Wei W; Wu Y
    Br J Pharmacol; 2023 Apr; 180(8):1017-1037. PubMed ID: 36623836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylenetetrahydrofolate reductase C677T genetic polymorphisms and risk of leukaemia among the North Indian population.
    Hussain SR; Naqvi H; Raza ST; Ahmed F; Babu SG; Kumar A; Zaidi ZH; Mahdi F
    Cancer Epidemiol; 2012 Aug; 36(4):e227-31. PubMed ID: 22441130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dendritic cell-based immunotherapy in acute and chronic myeloid leukaemia.
    Westers TM; Ossenkoppele GJ; van de Loosdrecht AA
    Biomed Pharmacother; 2007 Jul; 61(6):306-14. PubMed ID: 17368821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression patterns of costimulatory molecules on cells derived from human hematological malignancies.
    Zheng Z; Takahashi M; Aoki S; Toba K; Liu A; Osman Y; Takahashi H; Tsukada N; Suzuki N; Nikkuni K; Furukawa T; Koike T; Aizawa Y
    J Exp Clin Cancer Res; 1998 Sep; 17(3):251-8. PubMed ID: 9894758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient-individualized CD8⁺ cytolytic T-cell therapy effectively combats minimal residual leukemia in immunodeficient mice.
    Distler E; Albrecht J; Brunk A; Khan S; Schnürer E; Frey M; Mottok A; Jordán-Garrote AL; Brede C; Beilhack A; Mades A; Tomsitz D; Theobald M; Herr W; Hartwig UF
    Int J Cancer; 2016 Mar; 138(5):1256-68. PubMed ID: 26376181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Lineage switch - conversion of acute lymphoblastic leukaemia to acute myeloid leukaemia in 4 years old girl].
    Szpecht D; Derwich K; Wachowiak J; Konatkowska B; Dworacki G
    Med Wieku Rozwoj; 2008; 12(4 Pt 2):1041-4. PubMed ID: 19531823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-CD33 chimeric antigen receptor targeting of acute myeloid leukemia.
    O'Hear C; Heiber JF; Schubert I; Fey G; Geiger TL
    Haematologica; 2015 Mar; 100(3):336-44. PubMed ID: 25480499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New insights into Notch1 regulation of the PI3K-AKT-mTOR1 signaling axis: targeted therapy of γ-secretase inhibitor resistant T-cell acute lymphoblastic leukemia.
    Hales EC; Taub JW; Matherly LH
    Cell Signal; 2014 Jan; 26(1):149-61. PubMed ID: 24140475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunotherapy and cell therapy for myeloid leukemia].
    Yasukawa M
    Nihon Rinsho; 2009 Oct; 67(10):1938-43. PubMed ID: 19860194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human melanoma immunotherapy using tumor antigen-specific T cells generated in humanized mice.
    Hu Z; Xia J; Fan W; Wargo J; Yang YG
    Oncotarget; 2016 Feb; 7(6):6448-59. PubMed ID: 26824989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case report: Concomitant Chronic Lymphocytic Leukaemia and Cytogenetically Normal de novo Acute Leukaemia in a Patient.
    Kajtár B; Rajnics P; Egyed M; Alizadeh H
    Ann Clin Lab Sci; 2015; 45(5):602-6. PubMed ID: 26586717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell death by apoptosis in acute leukaemia.
    Baxter GD; Collins RJ; Harmon BV; Kumar S; Prentice RL; Smith PJ; Lavin MF
    J Pathol; 1989 Jun; 158(2):123-9. PubMed ID: 2754542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An inv(16)(p13q22) positive acute myeloid leukaemia relapsing as acute precursor B-cell lymphoblastic leukaemia.
    Boeckx N; van der Velden VH; Boogaerts M; Hagemeijer A; Vandenberghe P; van Dongen JJ
    Haematologica; 2004 Aug; 89(8):ECR28. PubMed ID: 15339697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.